Akorn, Inc. Reports Second Quarter 2006 Revenues Of $12.5 Million … - Business Wire (press release)
Akorn, Inc. Reports Second Quarter 2006 Revenues Of $12.5 Million …Business Wire (press release), CA - 1 hour ago… Seven product approvals were received from the FDA: Brimonidine, Inapsine(R), Orphenadrine, Sufenta(R), Alfenta(R), Amiodarone, and Dilitiazem. …
Read full story